427 EUR
3.5
0.83%
Last update Dec 17, 8:06 AM CET
Market closed
Day range
427
427
Previous close
423.5
Open
427
Access this stock data via API
Subscribe
United Therapeutics Corporation
427.00
3.50
0.83%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 2.5B 2.3B 1.9B 1.7B
Cost of revenue 264.0M 257.5M 151.6M 122.5M
Gross profit 2.2B 2.1B 1.8B 1.6B
Operating expense
Research & development 410.0M 408M 322.9M 540.1M
Selling general and admin 544.4M 477.1M 482.1M 467M
Other operating expenses
Operating income 1.2B 1.2B 979.7M 555.9M
Non operating interest income
Income 169.7M 162.7M 45.2M 16.7M
Expense 36.6M 59.3M 32.4M 18.6M
Other income expense -55.7M -14M -41.9M 39.9M
Pretax income 1.3B 1.3B 950.6M 593.9M
Tax provision 293.2M 289.5M 223.3M 118.1M
Net income 1.0B 984.8M 727.3M 475.8M
Basic EPS 26.4 21.0 16.0 10.6
Diluted EPS 24.6 19.8 15 10.1
Basic average shares 38.5M 49.1M 46.7M 46.1M
Diluted average shares 38.5M 49.1M 46.7M 46.1M
EBITDA 1.5B 1.4B 1.0B 664.7M
Net income from continuing op. 1.0B 984.8M 727.3M 475.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 1 hour 23 minutes

06:36
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).